The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases

Mangen M-JJ, Plaß D, Havelaar AH, Gibbons CL, Cassini A, Muehlberger N, van Lier A, Haagsma JA, Brooke RJ, Lai T, de Waure C, et al. (2013)
Plos One 8(11): e79740.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Abstract
In 2009, the European Centre for Disease Prevention and Control initiated the 'Burden of Communicable Diseases in Europe (BCoDE)' project to generate evidence-based and comparable burden-of-disease estimates of infectious diseases in Europe. The burden-of-disease metric used was the Disability-Adjusted Life Year (DALY), composed of years of life lost due to premature death (YLL) and due to disability (YLD). To better represent infectious diseases, a pathogen-based approach was used linking incident cases to sequelae through outcome trees. Health outcomes were included if an evidence-based causal relationship between infection and outcome was established. Life expectancy and disability weights were taken from the Global Burden of Disease Study and alternative studies. Disease progression parameters were based on literature. Country-specific incidence was based on surveillance data corrected for underestimation. Non-typhoidal Salmonella spp. and Campylobacter spp. were used for illustration. Using the incidence-and pathogen-based DALY approach the total burden for Salmonella spp. and Campylobacter spp. was estimated at 730 DALYs and at 1,780 DALYs per year in the Netherlands (average of 2005-2007). Sequelae accounted for 56% and 82% of the total burden of Salmonella spp. and Campylobacter spp., respectively. The incidence-and pathogen-based DALY methodology allows in the case of infectious diseases a more comprehensive calculation of the disease burden as subsequent sequelae are fully taken into account. Not considering subsequent sequelae would strongly underestimate the burden of infectious diseases. Estimates can be used to support prioritisation and comparison of infectious diseases and other health conditions, both within a country and between countries.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Mangen M-JJ, Plaß D, Havelaar AH, et al. The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One. 2013;8(11):e79740.
Mangen, M. - J. J., Plaß, D., Havelaar, A. H., Gibbons, C. L., Cassini, A., Muehlberger, N., van Lier, A., et al. (2013). The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One, 8(11), e79740. doi:10.1371/journal.pone.0079740
Mangen, M. - J. J., Plaß, D., Havelaar, A. H., Gibbons, C. L., Cassini, A., Muehlberger, N., van Lier, A., Haagsma, J. A., Brooke, R. J., Lai, T., et al. (2013). The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One 8, e79740.
Mangen, M.-J.J., et al., 2013. The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One, 8(11), p e79740.
M.-J.J. Mangen, et al., “The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases”, Plos One, vol. 8, 2013, pp. e79740.
Mangen, M.-J.J., Plaß, D., Havelaar, A.H., Gibbons, C.L., Cassini, A., Muehlberger, N., van Lier, A., Haagsma, J.A., Brooke, R.J., Lai, T., de Waure, C., Kramarz, P., Kretzschmar, M.E.E.: The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One. 8, e79740 (2013).
Mangen, Marie-Josee J., Plaß, Dietrich, Havelaar, Arie H., Gibbons, Cheryl L., Cassini, Alessandro, Muehlberger, Nikolai, van Lier, Alies, Haagsma, Juanita A., Brooke, R. John, Lai, Taavi, de Waure, Chiara, Kramarz, Piotr, and Kretzschmar, Mirjam E. E. “The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases”. Plos One 8.11 (2013): e79740.
This data publication is cited in the following publications:
This publication cites the following data publications:

15 Citations in Europe PMC

Data provided by Europe PubMed Central.

The Burden of Zoonoses in Kyrgyzstan: A Systematic Review.
Counotte MJ, Minbaeva G, Usubalieva J, Abdykerimov K, Torgerson PR., PLoS Negl Trop Dis 10(7), 2016
PMID: 27387925
Trends in the Burden of Hepatitis B in a Southern Brazilian State.
Marcon CE, Schneider IJ, Schuelter-Trevisol F, Traebert J., Hepat Mon 15(11), 2015
PMID: 26834790
Assessing disability weights based on the responses of 30,660 people from four European countries.
Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar ME, Speybroeck N, Salomon JA., Popul Health Metr 13(), 2015
PMID: 26778920
Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne Disease.
Devleesschauwer B, Haagsma JA, Angulo FJ, Bellinger DC, Cole D, Dopfer D, Fazil A, Fevre EM, Gibb HJ, Hald T, Kirk MD, Lake RJ, Maertens de Noordhout C, Mathers CD, McDonald SA, Pires SM, Speybroeck N, Thomas MK, Torgerson PR, Wu F, Havelaar AH, Praet N., PLoS ONE 10(12), 2015
PMID: 26633883
Incidence and Costs of Clostridium difficile Infections in Canada.
Levy AR, Szabo SM, Lozano-Ortega G, Lloyd-Smith E, Leung V, Lawrence R, Romney MG., Open Forum Infect Dis 2(3), 2015
PMID: 26191534
Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
Mangen MJ, Bouwknegt M, Friesema IH, Haagsma JA, Kortbeek LM, Tariq L, Wilson M, van Pelt W, Havelaar AH., Int. J. Food Microbiol. 196(), 2015
PMID: 25528537
The low global burden of trichinellosis: evidence and implications.
Devleesschauwer B, Praet N, Speybroeck N, Torgerson PR, Haagsma JA, De Smet K, Murrell KD, Pozio E, Dorny P., Int. J. Parasitol. 45(2-3), 2015
PMID: 24953055
Disease burden of selected gastrointestinal pathogens in Australia, 2010.
Gibney KB, O'Toole J, Sinclair M, Leder K., Int. J. Infect. Dis. 28(), 2014
PMID: 25281904
Relevance of Campylobacter to public health--the need for a One Health approach.
Golz G, Rosner B, Hofreuter D, Josenhans C, Kreienbrock L, Lowenstein A, Schielke A, Stark K, Suerbaum S, Wieler LH, Alter T., Int. J. Med. Microbiol. 304(7), 2014
PMID: 25266744
The global burden of listeriosis: a systematic review and meta-analysis.
Maertens de Noordhout C, Devleesschauwer B, Angulo FJ, Verbeke G, Haagsma J, Kirk M, Havelaar A, Speybroeck N., Lancet Infect Dis 14(11), 2014
PMID: 25241232
DALY calculation in practice: a stepwise approach.
Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, Haagsma JA, Praet N, Dorny P, Duchateau L, Torgerson PR, Van Oyen H, Speybroeck N., Int J Public Health 59(3), 2014
PMID: 24748107
Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011.
Colzani E, McDonald SA, Carrillo-Santisteve P, Busana MC, Lopalco P, Cassini A., Vaccine 32(16), 2014
PMID: 24530930
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods.
Gibbons CL, Mangen MJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, Peterson KL, Stuurman AL, Cassini A, Fevre EM, Kretzschmar ME; Burden of Communicable diseases in Europe (BCoDE) consortium., BMC Public Health 14(), 2014
PMID: 24517715

44 References

Data provided by Europe PubMed Central.

The costs of human Campylobacter infections and sequelae in the Netherlands: a DALY and cost-of-illness approach
AUTHOR UNKNOWN, 2005

AUTHOR UNKNOWN, 0
Foodborne illness acquired in the United States–unspecified agents. Emerg Infect Dis
AUTHOR UNKNOWN, 2011

AUTHOR UNKNOWN, 0
Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol
AUTHOR UNKNOWN, 2012

AUTHOR UNKNOWN, 0
Disease burden of post-infectious irritable bowel syndrome in The Netherlands.
Haagsma JA, Siersema PD, De Wit NJ, Havelaar AH., Epidemiol. Infect. 138(11), 2010
PMID: 20223049

AUTHOR UNKNOWN, 0
Clinical, epidemiological and pathogentic aspects of reactive arthritis
AUTHOR UNKNOWN, 1994

AUTHOR UNKNOWN, 0
Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991-2001.
van Pelt W, de Wit MA, Wannet WJ, Ligtvoet EJ, Widdowson MA, van Duynhoven YT., Epidemiol. Infect. 130(3), 2003
PMID: 12825727
Estimating the true incidence of campylobacteriosis and salmonellosis in the EU
AUTHOR UNKNOWN, 2013

AUTHOR UNKNOWN, 0
The burden of disease in Zimbabwe in 1997 as measured by disability-adjusted life years lost.
Chapman G, Hansen KS, Jelsma J, Ndhlovu C, Piotti B, Byskov J, Vos T., Trop. Med. Int. Health 11(5), 2006
PMID: 16640619
The burden of disease and injury in the United States 1996.
Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT, Ebrahim S, Ezzati M, Salomon JA, Kreiser JG, Hogan M, Murray CJ., Popul Health Metr 4(), 2006
PMID: 17049081
Systematic review of foodborne burden of disease studies: quality assessment of data and methodology.
Haagsma JA, Polinder S, Stein CE, Havelaar AH., Int. J. Food Microbiol. 166(1), 2013
PMID: 23827806
Risk Ranking for Foodborne Microbial Hazards in New Zealand: Burden of Disease Estimates
AUTHOR UNKNOWN, 2010

AUTHOR UNKNOWN, 0

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 24278167
PubMed | Europe PMC

Search this title in

Google Scholar